Skip to main content
Caplight Logo









Genotek

Genotek

Private
MoscowHealthcare & Life Scienceshttps://www.genotek.ru/

Last Round

VC Round

Dec 23, 2020

Est. Valuation

$5.71M

Total Funding Raised

$2.5M

Company Overview

Genotek is a biotechnology company that provides a platform for DNA testing services designed to give clients access to their genetic information.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Telemedicine

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

DTC DNA testingconsumer geneticsgenetic passportancestry testinggenetic health riskgenome analysispersonal genomicspharmacogeneticsfull genome sequencingexome sequencingsaliva DNA testDNA data interpretationprecision medicinebiotechnologytelemedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genotek Comparables

Compare Genotek with similar companies based on industry and business-model similarity.

Genotek comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
National Center for Genetic Research
83%
GenePlanet
77%
Mapmygenome
74%

Genotek Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 23, 2020
VC RoundDec 30, 2016
AngelFeb 10, 2016
SeedSep 1, 2013

Key People

Founding team and executive leadership

Федор Киреев

CEO of Yandex Health in Genotek

Executive Team

Genotek Investors

Notable investors and investment history

Genotek investors
InvestorRounds
PharmstandardVC Round
YandexVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Grew 17% QoQ, from 46 to 54 employees.

  • Mar 4, 2026

    Grew 20% QoQ, from 44 to 53 employees.

Genotek Filings

Explore SEC and related filing metadata, where available.

Genotek filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genotek's valuation, stock price, and market status.

Is Genotek a public or private company?

Genotek is a private company.

What is the current stock price of Genotek?

Genotek is a private company with no public stock price. No recent secondary market data is available.

How much is Genotek worth (valuation)?

Valuation information for Genotek is not publicly available.

Can I buy Genotek stock?

Genotek shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genotek's last funding round?

Genotek's most recent funding round was VC Round on December 23, 2020.

Who are the main investors in Genotek?

Key investors in Genotek include Pharmstandard, Yandex.

Will Genotek IPO soon?

No public IPO plans have been announced for Genotek.

How can I track Genotek secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genotek's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMoscow
Employee Range55
Year Founded2010
Last FundingDec 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?